57 false false false false false false false false false false true false false true false true true No description of principal activity 2024-06-01 Sage Accounts Production Advanced 2024 - FRS102_2024 350,000 245,000 105,000 105,000 xbrli:pure xbrli:shares iso4217:GBP 08053341 2024-06-01 2025-05-31 08053341 2025-05-31 08053341 2024-05-31 08053341 2023-06-01 2024-05-31 08053341 2024-05-31 08053341 2023-05-31 08053341 core:PlantMachinery 2024-06-01 2025-05-31 08053341 bus:Director2 2024-06-01 2025-05-31 08053341 core:NetGoodwill 2025-05-31 08053341 core:PlantMachinery 2025-05-31 08053341 core:WithinOneYear 2025-05-31 08053341 core:WithinOneYear 2024-05-31 08053341 core:AfterOneYear 2025-05-31 08053341 core:AfterOneYear 2024-05-31 08053341 core:ShareCapital 2025-05-31 08053341 core:ShareCapital 2024-05-31 08053341 core:RetainedEarningsAccumulatedLosses 2025-05-31 08053341 core:RetainedEarningsAccumulatedLosses 2024-05-31 08053341 core:NetGoodwill 2024-05-31 08053341 bus:Director1 2024-06-01 2025-05-31 08053341 bus:SmallEntities 2024-06-01 2025-05-31 08053341 bus:AuditExempt-NoAccountantsReport 2024-06-01 2025-05-31 08053341 bus:SmallCompaniesRegimeForAccounts 2024-06-01 2025-05-31 08053341 bus:PrivateLimitedCompanyLtd 2024-06-01 2025-05-31 08053341 bus:FullAccounts 2024-06-01 2025-05-31 08053341 core:NetGoodwill 2024-06-01 2025-05-31
COMPANY REGISTRATION NUMBER: 08053341

Eager Health Ltd

Filleted Unaudited Financial Statements

31 May 2025

Eager Health Ltd

Statement of Financial Position

31 May 2025

| 2025 | 2024
Note | £ | £ | £

Fixed assets

Intangible assets | 5 |  | 105,000 | 105,000

Current assets

Debtors | 7 | 33,236 |  | 143,699
Cash at bank and in hand | – |  | 35,802
| -------- |  | ---------
| 33,236 |  | 179,501

Creditors: amounts falling due within one year | 8 | 173,133 |  | 404,443
| --------- |  | ---------
Net current liabilities |  | 139,897 | 224,942
|  | --------- | ---------
Total assets less current liabilities |  | ( 34,897) | ( 119,942)

Creditors: amounts falling due after more than one year | 9 |  | 31,264 | 36,837
|  | -------- | ---------
Net liabilities |  | ( 66,161) | ( 156,779)
|  | -------- | ---------

Capital and reserves

Called up share capital |  | 120 | 120
Profit and loss account |  | ( 66,281) | ( 156,899)
|  | -------- | ---------
Shareholder deficit |  | ( 66,161) | ( 156,779)
|  | -------- | ---------

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
In accordance with section 444 of the Companies Act 2006, the income statement has not been delivered.
For the year ending 31 May 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Director's responsibilities:
- The member has not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476 ;
- The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .

Eager Health Ltd

Statement of Financial Position (continued)

31 May 2025
These financial statements were approved by the board of directors and authorised for issue on 17 February 2026 , and are signed on behalf of the board by:

Mr Manoj Gohil |
Director |

Company registration number: 08053341

Eager Health Ltd

Notes to the Financial Statements

Year ended 31 May 2025
1. General information
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is 136 St Albans Road, Watford, WD24 4FT, London.
2. Statement of compliance
These financial statements have been prepared in compliance with Section 1A of FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland'.
3. Accounting policies
Basis of preparation
The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss.
The financial statements are prepared in sterling, which is the functional currency of the entity.
Disclosure exemptions
The entity satisfies the criteria of being a qualifying entity as defined in FRS 102 and has applied the required disclosure exemptions available
Amortisation
Amortisation is calculated so as to write off the cost of an asset, less its estimated residual value, over the useful life of that asset as follows:

| Goodwill | - | Over 10 years

If there is an indication that there has been a significant change in amortisation rate, useful life or residual value of an intangible asset, the amortisation is revised prospectively to reflect the new estimates.
Depreciation
Depreciation is calculated so as to write off the cost or valuation of an asset, less its residual value, over the useful economic life of that asset as follows:

| Plant & machinery | - | 25% straight line
| Equipment | - | 25 % straight line

4. Employee numbers
The average number of persons employed by the company during the year amounted to 57 (2024: 47 ).
5. Intangible assets

| Goodwill
| £
Cost |
At 1 June 2024 and 31 May 2025 | 350,000
| ---------
Amortisation |
At 1 June 2024 and 31 May 2025 | 245,000
| ---------
Carrying amount |
At 31 May 2025 | 105,000
| ---------
At 31 May 2024 | 105,000
| ---------

6. Tangible assets

| Plant and machinery | Equipment | Total
| £ | £ | £
Cost |  |  |
At 1 June 2024 and 31 May 2025 | 5,882 | 16,266 | 22,148
| ------- | -------- | --------
Depreciation |  |  |
At 1 June 2024 and 31 May 2025 | 5,882 | 16,266 | 22,148
| ------- | -------- | --------
Carrying amount |  |  |
At 31 May 2025 | – | – | –
| ------- | -------- | --------
At 31 May 2024 | – | – | –
| ------- | -------- | --------

7. Debtors

| 2025 | 2024
| £ | £
Trade debtors | 20,113 | 73,524
Other debtors | 13,123 | 70,175
| -------- | ---------
| 33,236 | 143,699
| -------- | ---------

8. Creditors: amounts falling due within one year

| 2025 | 2024
| £ | £
Bank loans and overdrafts | 15,949 | 25,624
Trade creditors | – | 42,038
Corporation tax | 58,617 | 19,746
Social security and other taxes | 10,324 | 1,790
Deposit received | – | 43,685
Other creditors | 88,243 | 271,560
| --------- | ---------
| 173,133 | 404,443
| --------- | ---------

9. Creditors: amounts falling due after more than one year

| 2025 | 2024
| £ | £
Bank loans and overdrafts | 31,264 | 36,837
| -------- | --------

10. Financial instruments
There are no financial instruments requiring disclosure.
11. Director's advances, credits and guarantees
Other than as disclosed in creditors due within one year, there are no other material transactions with the directors.
12. Related party transactions
No transactions with related parties were undertaken such as are required to be disclosed under Financial Reporting Standard 102.